Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
about
Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed miceEvaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleMetastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model.Growth suppression of colorectal cancer by plant-derived multiple mAb CO17-1A × BR55 via inhibition of ERK1/2 phosphorylation.Unarmed, tumor-specific monoclonal antibody effectively treats brain tumorsDocumenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapym17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancerMacrophages are critical effectors of antibody therapies for cancerAntibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.Biologic response modifiers in the treatment of gastrointestinal malignancies.The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.Induction of a T- and B-cell response against a unique amino acid sequence of the mouse IgG2A hinge region in a MAb-treated patient.In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion moleculeBiological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic targetThe Gordon Wilson lecture. Monoclonal antibodies in human cancer.Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity.Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies.
P2860
Q21147009-A08D1FE3-D827-4B13-9464-0767354D2B21Q27469642-AA603BCD-F85E-46BD-A807-61FD0ACE1308Q27473287-B19AFFBE-173A-4CC6-BDDC-E6D0F4612E0AQ34002125-FC6BAE8E-4EBC-4B27-91A0-C28A02E49117Q34211752-FEB174DE-939E-4E89-9A40-F8BF4B244FA1Q34685644-9A8CCE67-77E6-4B5C-9CC8-644CA2DD6C6FQ35162055-11625092-B1D5-4248-B715-205DD83F3871Q35170266-DA0A0D87-D9B5-462A-8F76-E49946D98E6FQ35992797-436226C2-93E6-444A-BCEE-3A085CE0323FQ36079704-F2B704F2-A885-4E08-A361-CEE5D1ACA910Q36213288-A3C450DF-E8CF-4751-B19E-0464CB25A67EQ36356652-6F7D0457-4155-422A-9A0B-8B31E7715178Q36361038-28334CC4-A1D1-456E-9870-CE5F184E60CEQ37558378-164167FE-7C60-470A-9205-EEF8B340A282Q38646374-357F44B0-5DD1-4C99-8F8F-78D864FB180EQ39708585-5C2B2CFA-2DAB-405E-AE1B-E524E1A4C21FQ40644388-C66247DA-3A3B-4BB8-8EE5-D0D681B2935AQ40661240-85D74A72-77E1-470C-97A4-5CAED7891150Q40865882-7ACEC3DC-D4D9-4BCC-909B-6BE111B3B838Q41779247-9CCB8341-CDA7-414D-9688-559334B6F257Q42590724-FBCBB8C6-263F-40FD-800E-21CEA04C7549Q48755402-7F719FBC-FD3A-4886-8B6C-76C5A96690B6Q55004458-80202CAE-ED5A-4F8F-9DD5-30B5A5EC5C7E
P2860
Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@ast
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@en
type
label
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@ast
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@en
prefLabel
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@ast
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@en
P2093
P2860
P356
P1476
Tumors undergoing rejection in ...... antibody-dependent cytolysis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.11.3506
P407
P577
1984-06-01T00:00:00Z